Current Cancer Therapy Reviews publishes full-length review/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
Kurt S. Zäenker, a Professor at the University of Witten/Herdecke, Germany, is an immunologist and a tumor immunologist. He has authored and co-authored more than 650 publications and edited 24 books and special issues of journals. His research focuses on basic sciences in cell migration, a molecular pre-requisite for metastasis formation, and on cell fusion, a pre-requisite for new hybrid cell entities. In his role as an editor-in-chief and member of multiple scientific boards, review committees and scientific organizations, he takes responsibility for highest standards in research communication and development and education in medical science, and organized more than 20 internationally recognized conferences.